Enanta Pharmaceuticals In... (ENTA)
NASDAQ: ENTA
· Real-Time Price · USD
7.71
-0.03 (-0.39%)
At close: Aug 15, 2025, 2:12 PM
13F Institute Ownership
Total Institutes of 110 in Enanta Pharmaceuticals expanded their positions with an increase of 3 investors compared to the previous quarter. A reduction of 662.44K shares, as total invested capital declined by $11.66M with ownership percentage dropping from 90.82% to 87.47%.
Options Activity
Institutions are holding more Puts Contracts as Calls Contracts, indicating a bearish sentiment.
Put/Call 2.482
2.48
Call Flow 5,600
29%
Put Flow 13,900
71%
Top Shareholders
| Institute | Ownership | Shares | Shares % Change | Market Value | Portfolio | Filing Date |
|---|---|---|---|---|---|---|
| Farallon Capital Management Ll... | 9.97% | 2.12M | +0.66% | 11.71M | 0.06% | May 15, 2025 |
| Krensavage Asset Management, L... | 9.94% | 2.12M | -0.04% | 11.68M | 6.46% | May 15, 2025 |
| Blackrock, Inc. | 9.48% | 2.02M | -1.03% | 11.14M | < 0.01% | May 02, 2025 |
Stop Guessing, Start Knowing.
Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.
- Unlimited access to all data and tools
- Unlimited access to all data and tools, giving you the edge over everyone else in the market.
- Realtime Options & Dark Pool Data
- Instant access to live options & dark pool data to spot opportunities and trade with precision before the market moves.
- Top Wallstreet Analyst Ratings
- Follow ratings from the best analysts on Wall Street to stay ahead.
- Up to 30 years financial history
- We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.